Test ID: DCLNG Dilated Cardiomyopathy and Left Ventricular Noncompaction Cardiomyopathy Gene Panel, Varies
Ordering Guidance
This test is intended for genetic screening for and diagnosis of dilated cardiomyopathy or left ventricular noncompaction.
For comprehensive cardiomyopathy genetic testing, order CCMGG / Comprehensive Cardiomyopathy Gene Panel, Varies.
Customization of this panel and single gene analysis for any gene present on this panel are available. For more information see CGPH / Custom Gene Panel, Hereditary, Next-Generation Sequencing, Varies.
Targeted testing for familial variants (also called site-specific or known mutations testing) is available for the genes on this panel. See FMTT / Familial Variant, Targeted Testing, Varies. To obtain more information about this testing option, call 800-533-1710.
Shipping Instructions
Specimen preferred to arrive within 96 hours of collection.
Necessary Information
Prior Authorization is available, but not required, for this test. If proceeding with the prior authorization process, submit the required form with the specimen.
Specimen Required
Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. Call 800-533-1710 for instructions for testing patients who have received a bone marrow transplant.
Specimen Type: Whole blood
Container/Tube:
Preferred: Lavender top (EDTA) or yellow top (ACD)
Acceptable: Any anticoagulant
Specimen Volume: 3 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood specimen in original tube. Do not aliquot.
Specimen Stability Information: Ambient (preferred)/Refrigerated
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing (Spanish) (T826)
2. Hereditary Cardiomyopathies and Arrhythmias: Patient Information
3. Dilated Cardiomyopathy/LVNC Panel (DCLNG) Prior Authorization Ordering Instructions
4. If not ordering electronically, complete, print, and send a Cardiovascular Test Request Form (T724) with the specimen.
Useful For
Providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of dilated cardiomyopathy or left ventricular noncompaction
Establishing a diagnosis of a hereditary form dilated cardiomyopathy or left ventricular noncompaction
Genetics Test Information
This test utilizes next-generation sequencing to detect single nucleotide and copy number variants in 63 genes associated with hereditary forms of dilated cardiomyopathy and left ventricular noncompaction: ABCC9, ACAD9, ACADVL, ACTC1, ACTN2, ALMS1, ALPK3, BAG3, CDH2, CPT2, CRYAB, CSRP3, DES, DMD, DNAJC19, DOLK, DSC2, DSG2, DSP, EMD, FKRP, FKTN, FLNC, GAA, GLA, HCN4, JPH2, JUP, LAMP2, LMNA, MYBPC3, MYH7, MYLK3, MYPN, NEXN, NKX2-5, PCCA, PCCB, PKP2, PLN, PPA2, PPCS, PRDM16, RAF1, RBM20, RYR2, SCN5A, SGCD, SHOC2, SLC22A5, TAZ (TAFAZZIN), TBX20, TCAP, TMEM43, TMEM70, TNNC1, TNNI3, TNNI3K, TNNT2, TPM1, TTN, TTR, and VCL. See Targeted Genes and Methodology Details for Dilated Cardiomyopathy and Left Ventricular Noncompaction Cardiomyopathy Gene Panel and Method Description for additional details.
Identification of a disease-causing variant may assist with diagnosis, prognosis, clinical management, familial screening, and genetic counseling for hereditary forms of dilated cardiomyopathy and left ventricular noncompaction.
Prior Authorization is available for this assay.
Method Name
Sequence Capture and Targeted Next-Generation Sequencing followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing.
Reporting Name
Dilated Cardiomyopathy/LVNC PanelSpecimen Type
VariesSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Varies |
Clinical Information
The cardiomyopathies are a group of disorders characterized by disease of the heart muscle. Cardiomyopathy can be caused by inherited, genetic factors or by nongenetic (acquired) causes such as infection and inflammation.(1) When the presence or severity of the cardiomyopathy observed in a patient cannot be explained by acquired causes, genetic testing for the inherited forms of cardiomyopathy may be considered.
Hereditary forms of dilated cardiomyopathy (DCM) are characterized by ventricular dilation with reduced cardiac performance in the absence of other cardiac or systemic causes that may cause dilation of the heart muscle, such as hypertension and ischemic heart disease. The incidence of DCM in the general population is approximately 1 in 2500 (1), and it is estimated that approximately 50% of cases can be attributed to a genetic etiology.(1) Hereditary forms of DCM are most often caused by genes encoding proteins of the cardiac cytoskeleton and sarcomere.
Left ventricular noncompaction (LVNC) is characterized by prominent trabeculations of the left ventricle with trabecular recesses extending into the ventricular cavity. The incidence of LVNC in the general population is estimated to be 1 in 5000.(2) It is currently unclear if LVNC represents a genetically distinct form of cardiomyopathy, as many familial cases of LVNC have been linked to the same genes associated with other forms of hereditary cardiomyopathies, and many affected individuals also meet diagnostic criteria for DCM or hypertrophic cardiomyopathy.(2,3)
The clinical presentation of DCM and LVNC can be variable, even within the same family. DCM and LVNC can be apparently asymptomatic in some individuals but can cause sudden, life-threatening arrhythmias, increasing the risk of sudden cardiac death. In addition, some patients with primary hypertrophic cardiomyopathy or arrhythmogenic cardiomyopathy may eventually develop dilated ventricles, resembling DCM in later stages of disease progression.(1) DCM may also be a feature of an underlying systemic disorder such as amyloidoses and musculoskeletal conditions.(1)
Hereditary forms of DCM and LVNC can follow an autosomal dominant, autosomal recessive, and X-linked patterns of inheritance. Mitochondrial inheritance is also possible, however, genes associated with mitochondrial inheritance of DCM and LNVC are not assessed on this panel.
Reference Values
An interpretive report will be provided.
Interpretation
All detected variants are evaluated according to American College of Medical Genetics and Genomics recommendations.(4) Variants are classified based on known, predicted, or possible pathogenicity and reported with interpretive comments detailing their potential or known significance.
Clinical Reference
1. Bozkurt B, Colvin M, Cook J, et al; American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research: Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association Circulation. 2016 Dec 6;134(23):e579-e646. doi: 10.1161/CIR.0000000000000455. Erratum in: Circulation. 2016 Dec 6;134(23):e652
2. Ichida F: Left ventricular noncompaction-Risk stratification and genetic consideration. J Cardiol. 2020 Jan;75(1):1-9. doi: 10.1016/j.jjcc.2019.09.011
3. Aung N, Doimo S, Ricci F, et al: Prognostic significance of left ventricular noncompaction: Systematic review and meta-analysis of observational studies. Circ Cardiovasc Imaging. 2020 Jan;13(1):e009712. doi: 10.1161/CIRCIMAGING.119.009712
4. Richards S, Aziz N, Bale S, et al: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405-424
Day(s) Performed
Varies
Report Available
14 to 28 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81439
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
DCLNG | Dilated Cardiomyopathy/LVNC Panel | 51966-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
617240 | Test Description | 62364-5 |
617241 | Specimen | 31208-2 |
617242 | Source | 31208-2 |
617243 | Result Summary | 50397-9 |
617244 | Result | 82939-0 |
617245 | Interpretation | 69047-9 |
617246 | Additional Results | 82939-0 |
617247 | Resources | 99622-3 |
617248 | Additional Information | 48767-8 |
617249 | Method | 85069-3 |
617250 | Genes Analyzed | 48018-6 |
617251 | Disclaimer | 62364-5 |
617252 | Released By | 18771-6 |
mcl-moltechtestmenu; mcl-cardiology